Detalhe da pesquisa
1.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153814
2.
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report.
Haematologica
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721751
3.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Ann Hematol
; 103(1): 125-132, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731147
4.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932983
5.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335916
6.
Interferon regulatory factor 7 impairs cellular metabolism in aging adipose-derived stromal cells.
J Cell Sci
; 134(11)2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096605
7.
Update on the Role and Utility of Extracellular Vesicles in Hematological Malignancies.
Stem Cells
; 40(7): 619-629, 2022 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442447
8.
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes.
Cytotherapy
; 25(8): 803-807, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149800
9.
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.
Hematol Oncol
; 41(1): 16-25, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238977
10.
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia.
Cell Mol Life Sci
; 79(10): 521, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112236
11.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer
; 128(13): 2449-2454, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363892
12.
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
Hematol Oncol
; 40(5): 857-863, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932208
13.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854643
14.
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
Cancer
; 127(15): 2657-2665, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794557
15.
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells.
Br J Haematol
; 192(2): 333-342, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216963
16.
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
Br J Haematol
; 195(3): 371-377, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272724
17.
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Br J Haematol
; 193(2): 356-368, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222197
18.
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease.
Stem Cells
; 38(5): 698-711, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064745
19.
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition.
Cytotherapy
; 23(5): 368-372, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33714704
20.
Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells.
Cytotherapy
; 23(12): 1060-1063, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34116944